Page 202 - Genomic Medicine in Emerging Economies

Index 191

concept of, 177 personalized medicine, 115 Healthcare treatment
Golden Helix conferences, polymerase chain reaction, 111 European/Anglo-American
177, 179 training courses in hospital populations, 132
locations worldwide, 176 services/training seminars, 113 Low-Income European Countries
logos of, 163 use of genomic data, 142 and GNI values, 148
self-declared, lack of appropriate bioeconomy genomic Health Economic Assessment of Life
genomics education, 175 innovations, 4 with Teveten for Hypertension
Genomic medicine, 1, 14, 145, 146, education, 14 (HEALTH) model, 134
176, 180 ongoing, investment in, 10 Health insurances, 50
advance knowledge specific to, 14 historical perspective, 101 Health insurers, 132
awareness, 159 in human health, 4 Herb–drug interactions, 39
clinical implementation of, 13 implementation projects, Hereditary breast cancer, 28
collaboration between developed investments in, 2 Amerindian/European
and developing/resource- in resource-limited health care Ancestry
limited countries, 10 systems, 4 and breast cancer incidence, 29
definition, 49 successes, in the developing clinical and genetic features, 28
in developing countries, barriers world, 14 Latin American populations
to implementation of, 16 tests, 14 founder mutations in, 30
economic evaluation, 155 Genotype-first call-back, 184 mutational screening of BRCA1
goals of, 146 Genotyping, for HLA-B*1502, 134 and BRCA2, 30
graphical depiction of, 176 Global Genomic Medicine shared mutations among, 31
and resource-constrained Collaborative (G2MC) studies in cancer patients, 77
countries, 14 Conference, 10, 183 High-risk genotypes, 147
Genomic Medicine Alliance Global innovation, 8 High-throughput sequencing, 27
(GMA), 10, 146, 181 GMA. See Genomic Medicine HLA-B*5801 testing, 135
Ambassadors, 147 Alliance (GMA) HPV DNA screening, 136
Cancer Genomics Working Golden Helix Academy, 177, 5-HTTLPR profile, 135
Group, 152 182, 183 Human genetics, and health
Economic Evaluation in Genomic education, 183 system, 108
Medicine Working Group, 156 genomic literacy, 183 Human Genome Project, 13, 139
Genethics Working Group, 154 Golden Helix conferences, 170, 185 Human Molecular Genetics, 71
goals of, 146 Golden Helix Foundation, 146, 170, Human papillomavirus (HPV)
graphical depiction of, 176 174, 180, 181, 183, 184 testing, 135–136, 141
members, current research Golden Helix Foundation Human pregnane X receptor
projects, 147 International Scientific (PXR), 59
Public Health Genomics Advisory Council, 179 Hybridization methodologies, 108
Working Group, 182 Golden Helix Pharmacogenomics
Health Economics Working Days, 164, 181 I
Group, 184 past, 165 ICER. See Incremental
genome informatics working Golden Helix Summer Schools, cost-effectiveness ratio
group, 149 180–182 (ICER)
genomic medicine working group, past, 166 Incremental cost-effectiveness ratio
economic evaluation, 155 Golden Helix Symposia, 179, 180 (ICER), 133
pharmacogenomics working past, 177 Innovations, 13
group, 149 model, 8
working group, 153 H Institute of Medicine of the National
Public Health Genomics Working Healthcare delivery Academies of Sciences, 14
Group, 155 infrastructure, 132 International normalized ratio
Genomic Medicine Alliance Health care professionals, 2, 50 (INR), 134
International Scientific genetics education, 153 Irinotecan (CPT-11), 60
Advisory Committee, 148 genomic medicine, 145
Genomics, 4, 104 genomics education, 159, 175 K
in Argentina, 105 lack of genetics knowledge, 175
current status of, 142 Health care providers, 132 Knowledge, 1, 3, 14, 20, 27, 37, 49,
NGS technology, 143 Health care systems, 1 57, 76, 83, 105, 146, 153, 181